Operating Income Summary of Cochlear Limited

Cochlear Limited's latest annual operating income in 2024 was 521.5 Million AUD , up 26.45% from previous year.
Cochlear Limited's latest quarterly operating income in 2024 FY was 521.5 Million AUD , up 26.45% from previous quarter.
Cochlear Limited reported an annual operating income of 412.4 Million AUD in 2023, up 14.02% from previous year.
Cochlear Limited reported an annual operating income of 361.7 Million AUD in 2022, up 10.31% from previous year.
Cochlear Limited reported a quarterly operating income of 253.2 Million AUD for 2024 Q4, down 0.0% from previous quarter.
Cochlear Limited reported a quarterly operating income of 268.3 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Cochlear Limited (2024 - 1996)

Historical Annual Operating Income of Cochlear Limited (2024 - 1996)

Year	Operating Income	Operating Income Growth
2024	521.5 Million AUD	26.45%
2023	412.4 Million AUD	14.02%
2022	361.7 Million AUD	10.31%
2021	327.9 Million AUD	26.6%
2020	259 Million AUD	-26.61%
2019	352.9 Million AUD	2.23%
2018	345.2 Million AUD	9.52%
2017	315.2 Million AUD	24.14%
2016	253.9 Million AUD	23.72%
2015	205.23 Million AUD	34.36%
2014	152.74 Million AUD	-7.47%
2013	165.07 Million AUD	30.21%
2012	126.77 Million AUD	-46.96%
2011	239.02 Million AUD	10.44%
2010	216.42 Million AUD	24.32%
2009	174.08 Million AUD	21.91%
2008	142.8 Million AUD	4.07%
2007	137.21 Million AUD	45.68%
2006	94.19 Million AUD	36.22%
2005	69.14 Million AUD	54.91%
2004	44.63 Million AUD	-43.74%
2003	79.33 Million AUD	71.68%
2002	46.21 Million AUD	1415.49%
2001	-3.51 Million AUD	-69.71%
2000	-2.07 Million AUD	24.09%
1999	-2.72 Million AUD	-115.07%
1998	18.1 Million AUD	-75.18%
1997	72.92 Million AUD	22.13%
1996	59.71 Million AUD	0.0%

Year	Operating Income	Operating Income Growth
2024 FY	521.5 Million AUD	26.45%
2024 Q4	253.2 Million AUD	0.0%
2024 Q2	268.3 Million AUD	0.0%
2023 Q2	194.2 Million AUD	0.0%
2023 FY	412.4 Million AUD	14.02%
2023 Q4	218.2 Million AUD	0.0%
2022 Q4	154.6 Million AUD	0.0%
2022 Q2	207.1 Million AUD	0.0%
2022 FY	361.7 Million AUD	10.31%
2021 Q2	181.2 Million AUD	0.0%
2021 FY	327.9 Million AUD	26.6%
2021 Q4	150.6 Million AUD	0.0%
2020 Q2	199.6 Million AUD	0.0%
2020 FY	259 Million AUD	-26.61%
2020 Q4	59.4 Million AUD	0.0%
2019 Q2	176.4 Million AUD	0.0%
2019 Q4	176.5 Million AUD	0.0%
2019 FY	352.9 Million AUD	2.23%
2018 Q4	184.7 Million AUD	0.0%
2018 FY	345.2 Million AUD	9.52%
2018 Q2	160.5 Million AUD	0.0%
2017 Q4	161.4 Million AUD	0.0%
2017 FY	315.2 Million AUD	24.14%
2017 Q2	153.8 Million AUD	0.0%
2016 FY	253.9 Million AUD	23.72%
2016 Q4	128.77 Million AUD	0.0%
2016 Q2	125.13 Million AUD	0.0%
2015 Q4	105.35 Million AUD	0.0%
2015 Q2	99.88 Million AUD	0.0%
2015 FY	205.23 Million AUD	34.36%
2014 Q2	49.96 Million AUD	0.0%
2014 FY	152.74 Million AUD	-7.47%
2014 Q4	102.78 Million AUD	0.0%
2013 Q4	72.37 Million AUD	60.41%
2013 Q3	45.11 Million AUD	0.0%
2013 Q2	45.11 Million AUD	26.56%
2013 Q1	35.65 Million AUD	0.0%
2013 FY	165.07 Million AUD	30.21%
2012 Q4	- AUD	-100.0%
2012 Q2	35.65 Million AUD	-40.34%
2012 Q1	59.75 Million AUD	0.0%
2012 FY	126.77 Million AUD	-46.96%
2012 Q3	35.65 Million AUD	0.0%
2011 Q1	54.1 Million AUD	0.0%
2011 Q2	59.75 Million AUD	10.44%
2011 Q3	59.75 Million AUD	0.0%
2011 Q4	- AUD	-100.0%
2011 FY	239.02 Million AUD	10.44%
2010 FY	216.42 Million AUD	24.32%
2010 Q4	- AUD	-100.0%
2010 Q3	54.1 Million AUD	0.0%
2010 Q2	54.1 Million AUD	24.32%
2010 Q1	43.52 Million AUD	0.0%
2009 Q2	43.52 Million AUD	7.14%
2009 FY	174.08 Million AUD	21.91%
2009 Q3	43.52 Million AUD	0.0%
2009 Q1	40.62 Million AUD	0.0%
2009 Q4	- AUD	-100.0%
2008 Q1	38.58 Million AUD	0.0%
2008 Q2	40.62 Million AUD	5.29%
2008 Q4	- AUD	-100.0%
2008 FY	142.8 Million AUD	4.07%
2008 Q3	40.62 Million AUD	0.0%
2007 FY	137.21 Million AUD	45.68%
2007 Q3	38.58 Million AUD	0.0%
2007 Q4	- AUD	-100.0%
2007 Q2	38.58 Million AUD	43.07%
2007 Q1	26.96 Million AUD	0.0%
2006 FY	94.19 Million AUD	36.22%
2006 Q4	- AUD	-100.0%
2006 Q3	26.96 Million AUD	0.0%
2006 Q2	26.96 Million AUD	30.62%
2006 Q1	20.64 Million AUD	0.0%
2005 Q1	13.52 Million AUD	0.0%
2005 Q2	20.64 Million AUD	52.67%
2005 Q3	20.64 Million AUD	0.0%
2005 Q4	- AUD	-100.0%
2005 FY	69.14 Million AUD	54.91%
2004 Q1	19.83 Million AUD	0.0%
2004 FY	44.63 Million AUD	-43.74%
2004 Q2	13.52 Million AUD	-31.82%
2004 Q3	13.52 Million AUD	0.0%
2004 Q4	- AUD	-100.0%
2003 FY	79.33 Million AUD	71.68%
2003 Q2	19.83 Million AUD	55.68%
2003 Q1	12.74 Million AUD	0.0%
2003 Q3	19.83 Million AUD	0.0%
2003 Q4	- AUD	-100.0%
2002 FY	46.21 Million AUD	1415.49%
2002 Q2	12.74 Million AUD	-76.47%
2002 Q3	12.74 Million AUD	0.0%
2002 Q4	- AUD	-100.0%
2002 Q1	54.14 Million AUD	0.0%
2001 Q1	12.98 Million AUD	0.0%
2001 Q3	54.14 Million AUD	0.0%
2001 Q4	- AUD	-100.0%
2001 FY	-3.51 Million AUD	-69.71%
2001 Q2	54.14 Million AUD	317.12%
2000 Q4	- AUD	-100.0%
2000 FY	-2.07 Million AUD	24.09%
2000 Q2	12.98 Million AUD	28.57%
2000 Q1	10.09 Million AUD	0.0%
2000 Q3	12.98 Million AUD	0.0%
1999 Q3	10.09 Million AUD	0.0%
1999 Q2	10.09 Million AUD	28.68%
1999 Q1	7.84 Million AUD	0.0%
1999 FY	-2.72 Million AUD	-115.07%
1999 Q4	- AUD	-100.0%
1998 Q4	- AUD	-100.0%
1998 FY	18.1 Million AUD	-75.18%
1998 Q1	18.23 Million AUD	0.0%
1998 Q3	7.84 Million AUD	0.0%
1998 Q2	7.84 Million AUD	-56.96%
1997 Q4	- AUD	-100.0%
1997 Q1	14.92 Million AUD	0.0%
1997 Q2	18.23 Million AUD	22.13%
1997 Q3	18.23 Million AUD	0.0%
1997 FY	72.92 Million AUD	22.13%
1996 Q3	14.92 Million AUD	0.0%
1996 Q2	14.92 Million AUD	0.0%
1996 Q4	14.92 Million AUD	0.0%
1996 FY	59.71 Million AUD	0.0%

Peer Operating Income Comparison of Cochlear Limited

Name	Operating Income	Operating Income Difference
4DMedical Limited	-27.96 Million AUD	1964.747%
Adherium Limited	-11.98 Million AUD	4451.16%
Aroa Biosurgery Limited	-9.78 Million AUD	5428.113%
Atomo Diagnostics Limited	-4.36 Million AUD	12056.956%
Anteris Technologies Ltd	-66.63 Million AUD	882.649%
Control Bionics Limited	-5.92 Million AUD	8895.357%
CardieX Limited	-4.63 Million AUD	11354.473%
Compumedics Limited	-269 Thousand AUD	193966.171%
CleanSpace Holdings Limited	-4.81 Million AUD	10933.066%
Cyclopharm Limited	-9.22 Million AUD	5753.318%
EMVision Medical Devices Ltd	-1.61 Million AUD	32402.843%
Nova Eye Medical Limited	-3.79 Million AUD	13834.527%
HeraMED Limited	-6.42 Million AUD	8212.96%
Imricor Medical Systems, Inc.	-17.57 Million AUD	3067.225%
ImpediMed Limited	-19.03 Million AUD	2839.546%
InhaleRx Limited	-1.38 Million AUD	37713.046%
LBT Innovations Limited	-4.74 Million AUD	11102.11%
Micro-X Limited	-13.02 Million AUD	4103.224%
Neurotech International Limited	-5.58 Million AUD	9437.856%
OncoSil Medical Limited	-11.98 Million AUD	4451.56%
PolyNovo Limited	1.16 Million AUD	-44740.929%
Respiri Limited	-7 Million AUD	7549.787%
SomnoMed Limited	-3.84 Million AUD	13676.151%
Universal Biosensors, Inc.	-16.68 Million AUD	3226.439%
Uscom Limited	-2.4 Million AUD	21789.863%
Visioneering Technologies, Inc.	-5.85 Million AUD	9008.244%

Global Stocks Search

Cochlear Limited (COH.AX)

Operating Income Summary of Cochlear Limited

Annual Operating Income Chart of Cochlear Limited (2024 - 1996)

Historical Annual Operating Income of Cochlear Limited (2024 - 1996)

Peer Operating Income Comparison of Cochlear Limited